Yan Ning

3.0k total citations
105 papers, 2.4k citations indexed

About

Yan Ning is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yan Ning has authored 105 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Oncology, 21 papers in Pathology and Forensic Medicine and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yan Ning's work include Colorectal Cancer Treatments and Studies (51 papers), Genetic factors in colorectal cancer (20 papers) and Lung Cancer Treatments and Mutations (13 papers). Yan Ning is often cited by papers focused on Colorectal Cancer Treatments and Studies (51 papers), Genetic factors in colorectal cancer (20 papers) and Lung Cancer Treatments and Mutations (13 papers). Yan Ning collaborates with scholars based in United States, China and Italy. Yan Ning's co-authors include Dongyun Yang, Heinz‐Josef Lenz, Wu Zhang, Melissa J. LaBonte, Georg Lurje, Thomas Winder, Robert D. Ladner, Alexandra Pohl, Pierre Bohanes and Philipp Manegold and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Yan Ning

100 papers receiving 2.4k citations

Peers

Countries citing papers authored by Yan Ning

Since Specialization

Citations

This map shows the geographic impact of Yan Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Ning more than expected).

Fields of papers citing papers by Yan Ning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Ning. The network helps show where Yan Ning may publish in the future.

Co-authorship network of co-authors of Yan Ning

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Ning. A scholar is included among the top collaborators of Yan Ning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Ning. Yan Ning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of mobile health-based interventions to promote physical activity in patients with head and neck cancer: a qualitative study 2023 ·Frontiers in Public Health ·Yan Ning, Zhen Dong, (unknown), (unknown), (unknown), Qian Wang, Ruifang Zhu, (unknown)	2
2	Bedside nurses' antimicrobial stewardship practice scope and competencies in acute hospital settings: A scoping review 2023 ·Journal of Clinical Nursing ·(unknown), (unknown), (unknown), (unknown), Yan Ning, (unknown), (unknown), (unknown), (unknown)	4
3	Knowledge, Attitudes, and Practices of Bedside Nurses regarding Antimicrobial Stewardship in China: An Explanatory Sequential Mixed Methods Study 2023 ·Journal of Nursing Management ·(unknown), (unknown), (unknown), (unknown), Yan Ning, (unknown), (unknown), (unknown), (unknown), (unknown)	1
4	Application of NANDA-I nursing diagnoses, nursing interventions classification, and nursing outcomes classification in research and practice of cardiac rehabilitation nursing: A scoping review 2023 ·International Journal of Nursing Knowledge ·(unknown), (unknown), Yan Ning, (unknown)	2
5	Sublingual immunotherapy adherence in patients with allergic rhinitis: Effects of an intervention based on the information-motivation-behavioral skills model 2023 ·Heliyon ·(unknown), Ruifang Zhu, (unknown), Yan Ning, (unknown), Yan Feng, (unknown)	4
6	Evaluation of the quality of guidelines for sublingual immunotherapy of allergic rhinitis 2023 ·European Archives of Oto-Rhino-Laryngology ·(unknown), Ruifang Zhu, Yan Ning, (unknown), Yan Feng, (unknown)	2
7	Farnesoid X receptor: From Structure to Function and Its Pharmacology in Liver Fibrosis 2023 ·Aging and Disease ·Chuan Hun Ding, (unknown), Xinyue Dou, Qiao Yang, Yan Ning, (unknown), Xianan Sang, Min Hao, Kuilong Wang, Mengyun Peng, Shuosheng Zhang, Xin Han, Gang Cao	12
8	Identification of Key Molecules in Recurrent Miscarriage Based onBioinformatics Analysis 2021 ·Combinatorial Chemistry & High Throughput Screening ·Songping Luo, Jie Gao, (unknown), Yan Ning, Qing‐Ying Yu	5
9	Impact of genetic variations in the MAPK signaling pathway on outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizumab: data from FIRE-3 and TRIBE trials 2017 ·Annals of Oncology ·Martin D. Berger, Sebastian Stintzing, Volker Heinemann, Dongyun Yang, Shu Cao, Yu Sunakawa, Yan Ning, (unknown), Satoshi Okazaki, Yuji Miyamoto, Mitsukuni Suenaga, Marta Schirripa, Shivani Soni, W. Zhang, Alfredo Falcone, Fotios Loupakis, Heinz‐Josef Lenz	29
10	Prognostic Impact of IL6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy 2016 ·Clinical Cancer Research ·Satoshi Matsusaka, Diana L. Hanna, Shu Cao, Wu Zhang, Dongyun Yang, Yan Ning, Yu Sunakawa, Satoshi Okazaki, Martin D. Berger, (unknown), (unknown), Sebastian Stintzing, Fotios Loupakis, Heinz‐Josef Lenz	23
11	Polymorphisms in Genes Involved in EGFR Turnover Are Predictive for Cetuximab Efficacy in Colorectal Cancer 2015 ·Molecular Cancer Therapeutics ·Sebastian Stintzing, Wu Zhang, Volker Heinemann, Daniel Neureiter, Ralf Kemmerling, Thomas Kirchner, Andreas Jung, Matthias Folwaczny, Dongyun Yang, Yan Ning, Ana Sebio, Stefan Stremitzer, Yu Sunakawa, Satoshi Matsusaka, Shinichi Yamauchi, Fotios Loupakis, Chiara Cremolini, Alfredo Falcone, Heinz‐Josef Lenz	5
12	Cytokeratin-20 and Survivin-Expressing Circulating Tumor Cells Predict Survival in Metastatic Colorectal Cancer Patients by a Combined Immunomagnetic qRT-PCR Approach 2015 ·Molecular Cancer Therapeutics ·Yan Ning, Diana L. Hanna, Wu Zhang, Angela Mendez, Dongyun Yang, Rita El‐Khoueiry, Satoshi Matsusaka, Yu Sunakawa, Stefan Stremitzer, (unknown), Satoshi Okazaki, Martin D. Berger, Afsaneh Barzi, Heinz‐Josef Lenz	22
13	Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: results from TRIBE and FIRE3 trials 2015 ·Annals of Oncology ·Yu Sunakawa, Sebastian Stintzing, Shu Cao, Volker Heinemann, Chiara Cremolini, Alfredo Falcone, Dongyun Yang, W. Zhang, Yan Ning, Stefan Stremitzer, (unknown), Shinichi Yamauchi, (unknown), Satoshi Okazaki, Martin D. Berger, (unknown), Angela Mendez, (unknown), Fotios Loupakis, Heinz‐Josef Lenz	41
14	The CXCR2 Antagonist, SCH-527123, Shows Antitumor Activity and Sensitizes Cells to Oxaliplatin in Preclinical Colon Cancer Models 2012 ·Molecular Cancer Therapeutics ·Yan Ning, Melissa J. LaBonte, Wu Zhang, Pierre Bohanes, Armin Gerger, Dongyun Yang, Léonor Benhaïm, David Páez, David O. Rosenberg, Kalyan C. Nagulapalli Venkata, Stan G. Louie, Nicos A. Petasis, Robert D. Ladner, Heinz‐Josef Lenz	102
15	Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis 2012 ·British Journal of Cancer ·Yun Sok Lee, In Sil Choi, Yan Ning, (unknown), (unknown), Dongyun Yang, (unknown), (unknown), Melissa J. LaBonte, Robert D. Ladner, Kalyan C. Nagulapalli Venkata, David O. Rosenberg, Nicos A. Petasis, H-J Lenz, (unknown)	238
16	Cdk1, but not Cdk2, is the sole Cdk that is essential and sufficient to drive resumption of meiosis in mouse oocytes 2012 ·Human Molecular Genetics ·Deepak Adhikari, Wenjing Zheng, Yan Shen, Nagaraju Gorre, Yan Ning, Guillaume Halet, Philipp Kaldis, Kui Liu	118
17	Pharmacogenetic Angiogenesis Profiling for First-line Bevacizumab plus Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer 2011 ·Clinical Cancer Research ·Armin Gerger, Anthony B. El-Khoueiry, Wu Zhang, Dongyun Yang, Harpreet Singh, Pierre Bohanes, Yan Ning, Thomas Winder, Melissa J. LaBonte, Peter M. Wilson, Léonor Benhaïm, David Páez, Rita El‐Khoueiry, Gudrun Absenger, Heinz‐Josef Lenz	72
18	Germline Polymorphisms in Genes Involved in the IGF1 Pathway Predict Efficacy of Cetuximab in Wild-type KRAS mCRC Patients 2010 ·Clinical Cancer Research ·Thomas Winder, Wu Zhang, Dongyun Yang, Yan Ning, Pierre Bohanes, Armin Gerger, Peter M. Wilson, Alexandra Pohl, David J. Mauro, Christiane Langer, Eric K. Rowinsky, Heinz‐Josef Lenz	43
19	A let-7 microRNA-binding site polymorphism in 3′-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy 2010 ·Annals of Oncology ·(unknown), Thomas Winder, Yan Ning, (unknown), Dongyun Yang, Michael Kahn, Georg Lurje, Melissa J. LaBonte, P. M. Wilson, Michael A. Gordon, Siwen Hu‐Lieskovan, David J. Mauro, Christiane Langer, Eric K. Rowinsky, Heinz‐Josef Lenz	107
20	Interleukin‐8 is associated with proliferation, migration, angiogenesis and chemosensitivityin vitroandin vivoin colon cancer cell line models 2010 ·International Journal of Cancer ·Yan Ning, Philipp Manegold, Young Kwon Hong, Wu Zhang, Alexandra Pohl, Georg Lurje, Thomas Winder, Dongyun Yang, Melissa J. LaBonte, Peter M. Wilson, Robert D. Ladner, Heinz‐Josef Lenz	355

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact